Welcome to the UAE FIBROID registry!
What is the FIBROID registry?
How do I participate?
If I'm already registered, where do I enter my data?
What are the findings?
How do I get more information about UAE?

 |IRB submission|  |Patient Informed Consent| |Site registration form|  |Training Manual|  
|Core sites|  |Participating sites|  |Data access and publication policy| |Site newsletter|

All SIR members performing UAE are encouraged to participate. In order to contribute data to the registry, you will need internet access [Netscape™ and Internet Explorer™ browsers (version 4.0 and higher) running on Microsoft Windows 95, 98 NT4, or 2000 operating systems are required to support the UAE Registry web-based interface] and to complete the following three steps:

1).  Fax a
site registration form to Diane Minshall-Liu at the Duke Clinical Research Institute (DCRI), (919) 668-7027.

2).  Obtain institutional review board (IRB) approval (please see below for assistance in your application process). Fax this approval, along with a sample informed consent, to Diane Minshall-Liu at DCRI, (919) 668-7027.

3)  Agree to abide by the terms and conditions set forth in a site agreement between your institution and CIRREF.

Once these steps are completed, DCRI will then contact you with your username and password so that you may submit data to the registry via the web-based interface.  We suggest that you submit the necessary documents to your IRB as soon as possible, as this can be a lengthy process. 

 

If you have any questions, please feel free to contact Carolyn Strain or Nella Bloom at 703-691-1805.  If you need assistance or have any questions regarding your IRB submission and registration, please contact DCRI: Diane Minshall-Liu at 919-668-8221.

 

The deadline to enroll as a participating site in the Uterine Artery Embolization FIBROID Registry is July 1, 2002. We regret that we will be unable to accept applications after this date.

 

back to top


IRB submission

Documentation of IRB (Institutional Review Board) approval is required prior to submitting data to the registry. Every hospital and academic institution that conducts research has an IRB designed to protect the rights of patients and ensure that those participating in research studies are aware of the risks involved.  Many IRBs have developed standard language and/or a standard format for IRB submission. Standard language may be used in consent documents and is typically developed for those elements that deal with confidentiality, compensation, answers to questions, and the voluntary nature of participation. Each investigator should determine their local IRB's requirements before submitting.  

For those who are unfamiliar with submitting an application to their IRB , the process may seem intimidating at first, however submitting most applications is a relatively straightforward process. Many IRBs have a standard Research Review Application that you will submit along with the study protocol and patient informed consent. Feel free to use the provided template for submission which is addressed to the head of your local IRB and provides the purpose of the study and the study procedures.  

The following documents should be included with your IRB submission:

Registry synopsis  
Protocol
Sample informed consent (please note that the informed consent may be used as provided or may be modified to comply with institutional requirements/preferences)
FIBROID Registry Case Report Form (CRF)
  Baseline
  30 day follow-up

 

In addition, the FDA Web site: http://www.fda.gov/oc/oha/IRB/toc.html provides comprehensive information on the IRB process and clinical investigation requirements. This site used in conjunction with guidance from your local IRB should provide all of the necessary details. Additional materials that you may need to provide your IRB include the CV of the lead investigator and a précis on UAE.

 

The study protocol and informed consent must be reviewed and approved by the IRB at each center before subjects are enrolled in the study. Patients must sign an informed consent prior to registry enrollment. (Signed informed consent must be retained with the study records.) Evidence of IRB approval will be required on an annual basis.

 

Please fax a copy of your IRB approval and sample informed consent to Diane Minshall-Liu at the Duke Clinical Research Institute (DCRI) at (919) 668-7027.

 

back to top


Patient Informed Consent

 

Along with IRB approval, a copy of your site's patient informed consent for the Registry must be submitted to DCRI in order to participate in the Registry.  A sample informed consent is provided for your reference, but may need to be modified to comply with your institutional requirements/preferences.  If your site does modify the informed consent provided, please ensure that the final copy contains the basic elements detailed in the link.  For more detailed guidelines, please visit the National Institutes of Health Office of Human Subjects Research site: http://ohsr.od.nih.gov/info/finfo_6.php3.

 


Training Manual

 

The FIBROID Registry Training Manual provides comprehensive information on all aspects of the registry, including detailed information on collecting baseline data.  It is highly recommended that all sites review the manual before beginning data collection and use the manual for reference throughout the study.

 

Click here for a printable version of the entire document:

back to top


Core Sites

 

Lead Investigator

Institution

City

State

Country

James Benenati, MD

Miami Cardiac and Vascular Institute

Miami

FL

USA

Joseph Bonn, MD

Thomas Jefferson University Hospital

Philadelphia

PA

USA

David Brophy,MD

Mount Auburn Hospital

Boston

MA

USA

Jeffrey Dieden, MD

Kaiser Medical Center Oakland

Oakland

CA

USA

Karen Ehrman, MD

Methodist Hospital of Indiana

Indianapolis

IN

USA

Mark Garcia, MD

Christiana Care Health Systems

Newark

DE

USA

Joseph Gemmete, MD

University of Michigan

Ann Arbor

MI

USA

Michael Hines, MD

Kaiser Hospital Vallejo

Vallejo

CA

USA

David Hovsepian, MD

Mallinckrodt Institute of Radiology

St. Louis

MO

USA

Kevin Kim, MD

Johns Hopkins University

Baltimore

MD

USA

John Lipman, MD

Radiology Associates of Atlanta

Atlanta

GA

USA

Robert Min, MD

Cornell Vascular-- New York Presbyterian

New York

NY

USA

James Newman, MD, PhD

Cleveland Clinic Foundation

Cleveland

OH

USA

Gerald Niedwiecki, MD

Mease Countryside Hospital

Safety Harbor

FL

USA

Mahmood Razavi, MD

Stanford University Hospital

Palo Alto

CA

USA

Anne Roberts, MD

UCSD Medical Center

San Diego

CA

USA

William Romano, MD

William Beaumont Hospital

Royal Oak

MI

USA

Rajinder Sharma, MD

Henry Ford Hospital

Detroit

MI

USA

Richard Shlansky-Goldberg, MD

University of Pennsylvania

Philadelphia

PA

USA

David Siegel, MD

Long Island Jewish Medical Center

New Hyde Park

NY

USA

Gary Siskin, MD

Albany Medical Center

Albany

NY

USA

Steven Smith, MD

LaGrange Memorial Hospital

LaGrange

IL

USA

James Spies, MD

Georgetown University Hospital

Washington

DC

USA

Keith Sterling, MD

INVOA Alexandria Hospital

Alexandria

VA

USA

Robert Vogelzang, MD

Northwestern Memorial Hospital

Chicago

IL

USA

Robert Worthington-Kirsch, MD

Delaware Valley Imaging

Philadelphia

PA

USA

Moises Yoselevitz, MD

Ochsner Clinic Foundation

New Orleans

LA

USA

back to top


Participating Sites

Lead Investigator

Institution

City

State

Country

Philip Amatulle, MD

Vassar Brothers

Poughkeepsie

NY

USA

Raymond Ashleigh, MD

South Manchester University Hospitals NHS Trust

Manchester

England

Brian Baghdady, MD

Spartanburg Radiologic Associates

Spartanburg

SC

USA

Steven D.Brantley, MD

Quantum Radiology

Atlanta

GA

USA

Abbas Chamsuddin, MD

University of Tennessee Medical Group

Memphis

TN

USA

Man-kwong Chan, MD

Queen Elizabeth Hospital

Hong Kong

HK-SAR

Lee R. Christensen, MD

St. Francis Hospital and Medical Center

Blue Island

IL

USA

John Clouston, FRACR

Wesley Hospital

Brisbane

Australia

Mark Cockerill, MD

Sentara Virginia Beach General Hospital

Norfolk

VA

USA

Gregory J. Dubel, MD

Rhode Island Hospital

Providence

RI

USA

Simon Girling, MRCP, FRCR

Norfolk & Norwich University Hospital

Norwich

England

Jackeline Gomez-Jorge, MD

University of Miami/Jackson Memorial Medical Center

Miami

FL

USA

Gregory Gordon, MD

St. Luke's

Lincoln

NE

USA

Brian Hardy, MD

The University of Manitoba

Winnipeg

MB

Canada

Peter B. Hathaway, MD

St. Mark's Hospital

Salt Lake City

UT

USA

David A. Henry, MD

St. Francis Hospital

Milwaukee

WI

USA

Laura J. Hodges, MD

Greenwich Hospital

Greenwich

CT

USA

Trevor N. Hooper, MD

Gainesville Radiology Group

Gainesville

FL

USA

Keith Horton, MD

Washington Hospital Center

Washington

DC

USA

Linda Hughes, MD

Holy Cross Hospital

Ft. Lauderdale

FL

USA

Darren Hurst, MD

St. Elizabeth Medical Center

Edgewood

KY

USA

Gregory Karnaze, MD

Austin Radiological Associates

Austin

TX

USA

David J. Kastan, MD

St. Joseph Mercy Hospital

Ann Arbor

MI

USA

Chad G. Kelman, MD West Boca Medical Center Boca Raton
FL
USA
Paull M. Kiproff, MD

Allegheny General Hospital

Pittsburgh

PA

USA

Brian McInroy, MD Holy Spirit Hospital Lewisberry
PA
USA

Steven Meranze, MD

Vanderbilt University Medical Center

Nashville

TN

USA

Michael Miller, Jr., MD

Latrobe Area Hospital

Latrobe

PA

USA

Adrian Moger, MD

Mercy Hospital

Portland

ME

USA

J.G.Moss, MD

Gartnavel Hospital

Glasgow

Scotland

Tony Nicholson, MD

Hull and East Yorkshire Hospitals

Hull

England

John L. Nosher, MD

UMDNJ-Robert Wood Johnson

New Brunswick

NJ

USA

Carroll C. Overton, MD

Wake Medical Center

Raleigh

NC

USA

Steven H. Peck, MD

Rose Medical Center

Denver

CO

USA

Stuart Pollack, MD

Thunderbird Samaritan Medical Center

Glendale

AZ

USA

Donald Ponec, MD

Tri-City Medical Center

Oceanside

CA

USA

Douglas Powell, MD

Hillcrest Medical Center

Tulsa

OK

USA

Howard M. Richard, MD

University of Maryland Medical System

Baltimore

MD

USA

Marcos Roffe, MD St. Agnes Healthcare Baltimore
MD
USA
Folco Scappaticci, MD

Bristol Hospital

Bristol

CT

USA

Douglas C. Smith, MD Loma Linda University Medical Center Loma Linda
CA
USA
Efstathios Spinos, MD Chippenham Richmond
VA
USA
Brett Storm, MD Tallahassee Memorial Hospital Tallahassee
FL
USA
John Sunderland , MD Caritas Hospital Louisville
KY
USA
Joel Tennenhouse, MD St. John's Hospital Springfield
IL
USA
Corito S. Tolentino, MD El Camino Hospital Mountain View
CA
USA
Grant D.K. Urquhart, MD Southern General Hospital Glasgow
Scotland
Jonathan Uy, MD Franciscan Skemp Health Care La Crosse
WI
USA
Thomas Velling, MD Hoag Memorial Hospital Presbyterian Newport Beach
CA
USA

Evert-Jan Verschuyl, MD

Providence St. Peter Hospital

Olympia

WA

USA

Anthony Watkinson, MBBS Royal Free Hospital Hampstead
England

Kurt Wetzler, MD

Eastern Radiologists

Greenville

NC

USA

Bret N. Wiechmann, MD

North Florida Regional Medical Center

Gainesville

FL

USA

James A. York, MD Gwinett Medical Center Lawrenceville
GA
USA
Alan Zakheim, MD Englewood Hospital and Medical Center Englewood
NJ
USA
Darryl A. Zuckerman, MD University Hospital Cincinnati
OH
USA

For information on becoming a participating site, please go to the top of this page.

back to top


Site Newsletter

 

Click here for the UAE FIBROID Registry newsletter*: 

 

Archives

 

*Note to participating sites: These editions of the UAE FIBROID Registry newsletter have been targeted toward Core Sites. Information on longitudinal follow-up does not apply to participating sites.

back to top

   

©2001 CIRREF. All rights reserved.